The Effects of Snus on Home Blood Pressure and Metabolism
Snus with or without tobacco
Body Weight+8
+ Metabolic Diseases
+ Nutrition Disorders
Prevention Study
Summary
Study start date: October 9, 2023
Actual date on which the first participant was enrolled.This study explores how the use of snus, a form of smokeless tobacco placed under the lip, affects blood pressure and metabolism over time. It focuses on individuals who regularly used snus and then stopped. The study seeks to understand how resuming snus consumption might impact their blood pressure and metabolic health. By observing these changes, researchers aim to gain insights into the cardiovascular risks associated with snus, especially since it is less studied compared to smoking. This information could help in understanding the broader health implications of snus use, particularly its effect on long-term heart health. Participants in this study include 28 healthy adults who initially used snus daily. These participants will quit snus for three months, during which their blood pressure and various metabolic markers like cholesterol and blood sugar levels will be monitored. If any participants return to using snus during the study, these health metrics will continue to be tracked for another three months. Daily blood pressure recordings and reports of snus usage will be collected. Participants will undergo specific health checks at the start and during the study to evaluate changes in weight and blood components such as glucose and cholesterol. They will receive compensation for their participation, and all procedures will follow ethical guidelines to ensure safety and informed consent.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.28 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Primary Health Care Center Cityhälsan Centrum
Norrköping, SwedenOpen Primary Health Care Center Cityhälsan Centrum in Google Maps